Key result
Bicuspid aortic valve-preserving surgery demonstrated low operative mortality, 82-100% 5-year survival, and 43-100% 5-year freedom from reoperation.
Why the study?
Does bicuspid aortic valve-preserving surgery provide safe, efficacious, and durable outcomes in patients with bicuspid aortic valve disease?
Systematic Review
Does bicuspid aortic valve-preserving surgery provide safe, efficacious, and durable outcomes in patients with bicuspid aortic valve disease?
Bicuspid aortic valve repair demonstrates low operative mortality and excellent 5-year survival, though variability in 5-year freedom from reoperation highlights the need for standardized durability assessments.
Answers are grounded in this paper and cite their sources.
Supports valve-preserving surgery in suitable bicuspid aortic valve patients; confirms safety and survival yet leaves durability standardization open.
Valve repair has emerged as an important intervention for the management of bicuspid aortic valve disease. This systematic review aims to assess the safety, efficacy and durability of bicuspid aortic valve repair. Initial searches yielded 682 abstracts, reduced by de-duplication to 370, of which 56 full papers were accessed and 30 met the inclusion criteria. Overall, 163 unique outcomes for bicuspid aortic valve-preserving surgery were reported on 280 occasions. Bicuspid aortic valve-preserving surgery exhibited low operative mortality (0.0-5.2%), excellent 5-year survival (82-100%) and 43-100% 5-year freedom from reoperation. Bicuspid aortic valve repair is safe and efficacious, but concerns regarding its durability necessitate further standardized outcome assessments.
No takes yet. Share an insight, caveat, or question.
Vohra et al. (2013) conducted a systematic review in Bicuspid aortic valve disease. Bicuspid aortic valve-preserving surgery was evaluated on Operative mortality, 5-year survival, and 5-year freedom from reoperation. Bicuspid aortic valve-preserving surgery demonstrated low operative mortality, 82-100% 5-year survival, and 43-100% 5-year freedom from reoperation.
Synapse has enriched 10 related papers. Consider them for comparative context: